Study of serum level and immunohistochemical expression of von Willebrand factor in psoriasis

References

• Michalek, I. M.; Loring, B.; John, S. M. Asystemic Review of Worldwide Epidemiology of Psoriasis. J. Eur. Acad. Dermatol. Venerol. 2017, 31(2), 205–207. DOI: https://doi.org/10.1111/jdv.13854.
   PubMed Web of Science ®Google Scholar
• Flamer, A. J.; Ruschitzka, F. Psoriasis and Atherosclerosis: Two Plaques, One Syndrome? Eur. Heart J. 2012, 33(16), 1989–1991. DOI: https://doi.org/10.1093/eurheartj/ehr425.
   PubMed Web of Science ®Google Scholar
• Ogawa, E.; Sato, Y.; Minagawa, A.; Okuyama, R. Pathogenesis of Psoriasis and Development of Treatment. J. Dermatol. 2018, 45(3), 264–272. DOI: https://doi.org/10.1111/1346-8138.14139.
   PubMed Web of Science ®Google Scholar
• Liew, S. C.; Das-Gupta, E.; Chakravarthi, S.; Wong, S. F.; Lee, N.; Safdar, N.; Jamil, A. Differential Expression of the Angiogenesis Growth Factors in Psoriasis Vulgaris. BMC Res. Notes. 2012, 5(1), 201.
   PubMedGoogle Scholar
• Lenting, P. J.; Casari, C.; Christophe, O. D.; Denis, C. V. Von Willebrand Factor: The Old, the New and the Unknown. J. Thromb. Haemost. 2012, 10(12), 2428. DOI: https://doi.org/10.1111/jth.12008.
   PubMed Web of Science ®Google Scholar
• Gragnano, F.; Sperlongano, S.; Golia, E.; Natale, F.; Bianchi, R.; Crisci, M.; Fimiani, F.; Pariggiano, I.; Diana, V.; Carbone, A.;; et al. The Role of Von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators Inflammation. 2017, 20(3), 883–891.
   Google Scholar
• Makin, A. J.; Blann, A. D.; Chung, N. A.; Silvernan, S. H.; Lip, G. Y. Assessment of Endothelial Damage in Atherosclerotic Vascular Disease by Quantification of Circulating Endothelial Cells. Relationship with Von Willebrand Factor and Tissue Factor. Eur. Heart J. 2004, 25(5), 371–376. DOI: https://doi.org/10.1016/j.ehj.2003.04.001.
   PubMed Web of Science ®Google Scholar
• Meucci, G.; Pareti, F.; Vecchi, M.; Saibeni, S.; Bressi, C.; de Franchis, R. Serum Von Willebrand Factor Levels in Patients with Inflammatory Bowel Disease are Related to Systemic inflammation.Scand. J. Gastroenterol. 1999, 34(3), 287–290.
   Web of Science ®Google Scholar
• Nossent, J.- C.; Raymond, W.- D.; Eilertsen, G.- Ø. Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation. Lupus science & Medicine 2016,3:162-169.
   Google Scholar
• Kural, B. V.; Orem, A.; Cimsit, G.; Ha, U.; Yandi, Y. E.; Alver, A. Plasma Homocysteine and Its Relationships with Atherothrombotic Markers in Psoriasis Patients. Clin. Chim. Acta. 2003, 332(1–2), 23–30. DOI: https://doi.org/10.1016/S0009-8981(03)00082-2.
   PubMed Web of Science ®Google Scholar
• De Valk-De Roo, G. W.; Stehouwer, C. D.; Lambert, J.; Schalkwijk, C. G.; Van Der Mooren, M. J.; Kluft, C.; Netelenbos, C. Plasma Homocysteine Is Weakly Correlated with Plasma Endothelin and Von Willebrand Factor but Not with Endothelium-dependent Vasodilatation in Healthy Postmenopausal Women. Chem. Chem. 1999, 45(8), 1200–1205.
   Google Scholar
• Ozlem, K.; Rifat, E.; Alev, A.; Emrullah, S.; Bilal, D.; Yavuz, H. Inflammation and Hypercoagulable State in Adult Psoriatic Men. Acta Derm. Venereol. 2008, 88(4), 337–340. DOI: https://doi.org/10.2340/00015555-0456.
   PubMed Web of Science ®Google Scholar
• Batycka-Baran, A.; Paprocka., M.; Krawczenko, A.; Duś, D.; Szepietowski, J. C. Increased Number of Circulating Endothelial Cells (Cecs) in Patients with Psoriasis. JEADV. 2012, 2014(28), 116–119.
   Google Scholar
• Blann, A. D.; Woywodt, A.; Bertolini, F.; Bull, T. M.; Buyon, J. P.; Clancy, R. M.; Haubitz, M.; Hebbel, R. P.; Lip, G. Y.; Mancuso, P.; et al. Circulating Endothelial Cells. Biomarker of Vascular Disease. Thromb. Haemost. 2005, 93(2), 228–235.
   PubMed Web of Science ®Google Scholar
• Marongiu, F.; Sorano, G. G.; Bibbo, C.; Pistis, M. P.; Conti, M.; Mulas, P.; Balestrieri, A.; Biggio, P. Abnormalities of Blood Coagulation and Fibrinolysis in Psoriasis. Dermatology. 1994, 189(1), 32–37. DOI: https://doi.org/10.1159/000246755.
   PubMed Web of Science ®Google Scholar
• Malerba, M.; Gisondi, P.; Radaeli, A.; Sala, R.; Calzavara, P.- G.; Girolomoni, G.- Plasma homocystein and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006; 155: 1165–1169.
   Google Scholar
• Yiu, K.- H.; Yeung, C.- K.; Chan, H.- T.; Wong, R.- M.; Tam, S.; Lam, K.- F.; Yan, G.- H.; Yue, W.- S.; Chan, H.- H.; Tse, H.- F. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol. 2011;164(3):514-20.
   Google Scholar
• Sankar, L.; Arumugam, D.; Boj, S.; Pradeep, P. Expression of Angiogenic Factors in Psoriasis Vulgaris. J. Clin. Diagn. Res. 2017, 11(3), 23–27.
   Web of Science ®Google Scholar
• Nofal, A.; Al Makhzangy, I.; Attwa, E.; Nassar, A.; Abdalmoati, A. Vascular Endothelial Growth Factor in Psoriasis: An Indicator of Disease Severity and Control. J. Eur. Acad. Dermatol. Venereol. 2009, 23(7), 803–806. DOI: https://doi.org/10.1111/j.1468-3083.2009.03181.x.
   PubMed Web of Science ®Google Scholar
• Ahmed, S.; Amin, N.; Abdalla, K.; Farag, R.; ElKasheshy, K. Role of Vascular Endothelial Growth Factor, Survivin, and Inducible Nitric Oxide Synthase Expression in Psoriasis: An Immunohistochemical Study. Egypt. J. Dermatol. Venereol. 2014, 34(1), 21–26. DOI: https://doi.org/10.4103/1110-6530.137262.
   Google Scholar
• Henno, A.; Blacher, S.; Lambert, C.; Deroanne, C.; Noel, A. Histological and Transcriptional Study of Angiogenesis and Lymphangiogenesis in Uninvolved Skin, Acute Pinpoint Lesions and Established Psoriasis Plaques: An Approach of Vascular Development Chronology in Psoriasis. J. Dermatol. Sci. 2010, 57(3), 162–169. DOI: https://doi.org/10.1016/j.jdermsci.2009.12.006.
   PubMed Web of Science ®Google Scholar
• Siaw-Cheok, L.; Das-Gupta, E.; Srikumar, C.; Wong, S. F.; Lee, N.; Safdar, N.; Jamil, A. Differential Expression of the Angiogenesis Growth Factors in Psoriasis Vulgaris. BMC Res. Notes. 2012, 5(1), 201.
   PubMedGoogle Scholar
• Gębska, E.; Sikora-Żydek, A.; Michalski, M.; Reichman-Warmusz, E.; Kurek, J.; Dudek, D.; Skowron, W.; Jarząb, J.; Wojnicz, R. Tissue Hemostasis Is Shifted toward Thrombogenesis in the Psoriatic Plaques. Pathol. Res. Pract. 2017, 213(9), 1125–1129. DOI: https://doi.org/10.1016/j.prp.2017.07.011.
   PubMed Web of Science ®Google Scholar
• Rashed Hayam, E.; El-Bary, A.; Eman, H. Immunohistochemical Evaluation of VEGF, Survivin, Bcl-2 Protein and iNOS in the Pathogenesis of Psoriasis. Egypt. J. Pathol. 2012, 32(1), 91–98. DOI: https://doi.org/10.1097/01.XEJ.0000417556.36570.93.
   Google Scholar
• Bhushan, M.; Mc Laughlin, B.; Weiss, J.; Griffits, C. E. M. Levels of Endothelial Cell Stimulating Angiogenesis Factor and Vascular Endothelial Growth Factor are Elevated in Psoriasis. Br. J. Dermatol. 2001, 141(6), 1054–1060. DOI: https://doi.org/10.1046/j.1365-2133.1999.03205.x.
   Web of Science ®Google Scholar